Literature DB >> 18657370

TRH and TRH-like peptide expression in rat following episodic or continuous corticosterone.

Albert Eugene Pekary1, Albert Sattin, James Blood, Stephanie Furst.   

Abstract

Sustained abnormalities of glucocorticoid levels have been associated with neuropsychiatric illnesses such as major depression, posttraumatic stress disorder (PTSD), panic disorder, and obsessive compulsive disorder. The pathophysiological effects of glucocorticoids may depend not only on the amount of glucocorticoid exposure but also on its temporal pattern, since it is well established that hormone receptors are down-regulated by continuously elevated cognate hormones. We have previously reported that TRH (pGlu-His-Pro-NH2) and TRH-like peptides (pGlu-X-Pro-NH2) have endogenous antidepressant-like properties and mediate or modulate the acute effects of a single i.p. injection of high dose corticosterone (CORT) in rats. For these reasons, two accepted methods for inducing chronic hyperglucocorticoidemia have been compared for their effects on brain and peripheral tissue levels of TRH and TRH-like peptides in male, 250 g, Sprague-Dawley rats: (1) the dosing effect of CORT hemisuccinate in drinking water, and (2) s.c. slow-release pellets. Overall, there were 93% more significant changes in TRH and TRH-like peptide levels in brain and 111% more in peripheral tissues of those rats ingesting various doses of CORT in drinking water compared to those with 1-3 s.c. pellets. We conclude that providing rats with CORT in drinking water is a convenient model for the pathophysiological effects of hyperglucocorticoidemia in rodents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657370     DOI: 10.1016/j.psyneuen.2008.06.001

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  5 in total

1.  Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice.

Authors:  Shannon L Gourley; Jonathan W Espitia; Gerard Sanacora; Jane R Taylor
Journal:  Psychopharmacology (Berl)       Date:  2011-07-21       Impact factor: 4.530

2.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

Review 3.  Review of recent advances in analytical techniques for the determination of neurotransmitters.

Authors:  Maura Perry; Qiang Li; Robert T Kennedy
Journal:  Anal Chim Acta       Date:  2009-09-01       Impact factor: 6.558

4.  Action control is mediated by prefrontal BDNF and glucocorticoid receptor binding.

Authors:  Shannon L Gourley; Andrew M Swanson; Andrea M Jacobs; Jessica L Howell; Michelle Mo; Ralph J Dileone; Anthony J Koleske; Jane R Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

5.  Caveats of chronic exogenous corticosterone treatments in adolescent rats and effects on anxiety-like and depressive behavior and hypothalamic-pituitary-adrenal (HPA) axis function.

Authors:  Patti Waters; Cheryl M McCormick
Journal:  Biol Mood Anxiety Disord       Date:  2011-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.